A potential hurdle for molecular imaging with
paramagneticMR contrast agents (e.g. iron oxides)
entails the anticipated sparseness of the molecular
epitopes on targeted cell surfaces (e.g., nanomolar
concentrations), in concert with the modest signal
intensity from conventional paramagnetic contrast
agents, which may result in insufficient contrast-to-noise
ratio (CNR) for diagnosticimag ing